Skip to nav Skip to content

CDC/IDSA COVID-19 Clinician Call: Neurologic Manifestations in Patients with COVID-19

Facebook Twitter LinkedIn Email

These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Read responses to unanswered questions and register for next week here


  • Dana S. Wollins, DrPH, MGC
    Vice President, Clinical Affairs & Practice Guidelines, IDSA


  • Andrew Russman, DO, FAHA, FAAN
    Head, Cleveland Clinic Stroke Program
    Medical Director, Comprehensive Stroke Center
    Staff, Vascular Neurology
    Cleveland Clinic
  • James J. Sejvar, MD
    Division of High-Consequence Pathogens and Pathology
    National Center for Emerging and Zoonotic Infectious Diseases
    Centers for Disease Control and Prevention

*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.